A team of Finnish trialists have carried out the most far-ranging clinical trial on the subject a study carried out in a tiny room at the National Institute of Health in Helsinki. Anna Stavubchenko a senior researcher at the university hospital helped supervise it.
Contrary to traditional belief the applicator technique used in the current study did not blind patients or cause any problems. The results were published in the prestigious scientific journal PNAS this month.
Red spot yellow stripes.
CSIC Health has carried out this trial in 13 hospitals in Finland. This is the first time in Finland that such a groundbreaking clinical trial has been carried out on a newborn.
It was carried out entirely on volunteers. The first improvement was that in the first place the proportion of positive patients was double that in the initial stage of the study.
The biggest problem was that during the first 12 weeks after the procedure the patients showed red spots on the skin. The people who underwent the procedure were astonished and went from noticing them once a day to completely forgetting them. Clients who experienced a previous location-related skin lesion did not get affected.
A special gel has been used for five years. It is easy to apply and the skin produces less red spots in the summer.
The study is carried out in a temporary hospital with 28 volunteers. The most significant aspect is that after the first month the volunteers no longer have to follow all the guidelines.
Tough on the head.
According to the results of the study which was carried out on 6000 volunteers the patients showed a substantial improvement in their Crohns disease symptoms. However less than half of the patients experienced any serious effects. The most affected patients suffered the least possible adverse effects from the procedure. None of the score scales were affected by the procedure.
As it was also noted that the patients who received a vasectomy were the ones who improved the most as compared to other groups.
How it is done.
The study was carried out in a virtual-reality (VR) institute at the helmetvr facility where people have the impression that it is a real laboratory with scientists sitting there without the risk of exposure of bacteria. This is the case.